Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/27/2024 10:52:21 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 1187
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49869
dunno .. imo NR signaled yesterday potential to
(1)
4kids
10/12/2018 2:25:35 PM
49868
the latter having been acquired by Pfizer in 2016
smokenhot
10/12/2018 2:09:41 PM
49867
Compare the "tingling" side effect of Brilacidin
(4)
Drano
10/12/2018 2:08:26 PM
49866
I absolutely agree with you. I just wanted to
(2)
RusticBum
10/12/2018 2:05:33 PM
49865
Could be...Leo could hand out $100 bills and
Commando911
10/12/2018 2:01:04 PM
49864
See 11 buys at .20 off the time and sales
(1)
NotRichYet2
10/12/2018 2:00:37 PM
49863
Ask is back at .20. They are probably trying to
(2)
Drano
10/12/2018 1:58:52 PM
49862
Maybe. Guessing they just couldn't find a 0.20
(2)
Squar
10/12/2018 1:35:53 PM
49861
yep and after hitting *high* of the day (HOD) ..
(3)
4kids
10/12/2018 1:34:32 PM
49860
Bid/ask was .18/.20 but that looked too positive
Drano
10/12/2018 1:30:34 PM
49859
yep PR email time stamp shows 1:17PM .. i have
(1)
4kids
10/12/2018 1:30:02 PM
49858
Oops, Im slow to trigger
Commando911
10/12/2018 1:24:01 PM
49857
Innovation Pharmaceuticals Brilacidin as a Novel
Commando911
10/12/2018 1:23:10 PM
49856
News just arrived via email. I agree nicely
AlanC
10/12/2018 1:22:28 PM
49855
Had a partial order fill just prior to the PR
(2)
4kids
10/12/2018 1:20:57 PM
49854
That isn't quite correct. PolyMedix had limited
(1)
Drano
10/12/2018 1:17:34 PM
49853
what i really like about today's update was its
(1)
4kids
10/12/2018 1:14:26 PM
49852
It's actually worse with Poly. They did lab tests
RusticBum
10/12/2018 1:13:58 PM
49851
Nice update! Keep working the plan Leo! Go
(2)
AlanC
10/12/2018 1:03:55 PM
49850
Yes, I was thinking about that also. There is
(1)
Jimmyboy
10/12/2018 12:49:52 PM
49849
You can tell that Leo DID NOT write that one --
(1)
Drano
10/12/2018 12:45:28 PM
49848
I'm convinced we are going to see some MAJOR
(1)
smokenhot
10/12/2018 12:28:16 PM
49847
Makes one wonder if it is the BP that is holding
(1)
petemantx
10/12/2018 12:27:38 PM
49846
It is amazing reading how varied are the pathways
(2)
petemantx
10/12/2018 12:23:29 PM
49845
Innovation Pharmaceuticals Brilacidin as a Novel
(3)
4kids
10/12/2018 12:20:13 PM
49844
Nice. They just keep connecting thise Celgene
Squar
10/12/2018 12:15:49 PM
49843
Innovation Pharmaceuticals Brilacidin as a Novel
(1)
BooDog
10/12/2018 12:15:12 PM
49842
IPIX News PDE4
(4)
smokenhot
10/12/2018 12:06:58 PM
49840
Well, with all the IPIX wealth we will soon have
Squar
10/12/2018 11:51:21 AM
49839
Ugh. Opdivo doesn't work for lung cancer.
Drano
10/12/2018 11:37:58 AM
49838
Absolutely. Just get ahold of a federal combined
(2)
BooDog
10/12/2018 10:06:59 AM
49837
"It's called distort and it has worked great
(4)
Kelt
10/12/2018 9:56:49 AM
49836
It's clear that people can't do their own
(5)
bejamin
10/12/2018 9:52:03 AM
49835
" All the recent volume is selling pressure.."
(5)
Kelt
10/12/2018 9:49:50 AM
49833
Many of the large non-profits like the cancer
(5)
Drano
10/12/2018 9:45:30 AM
49832
Every stock carries with it a RISK/REWARD factor.
(1)
NotRichYet2
10/12/2018 9:42:42 AM
49831
You attack the moderators and the bullish
(5)
Drano
10/12/2018 9:39:46 AM
49830
Yes, everyone that has been long this stock and
(1)
Jimmyboy
10/12/2018 9:24:41 AM
49829
I thought it was set up to be able to discuss
(5)
bejamin
10/12/2018 9:19:07 AM
49828
Let's see the partnership or BTD news in the next
BooDog
10/12/2018 9:17:56 AM
49827
JUST FOR THE RECORD --- DRANO is "NOT" the only
(2)
NotRichYet2
10/12/2018 9:17:12 AM
49826
That's what the ignore feature is for. Or at
(2)
BooDog
10/12/2018 9:05:29 AM
49825
This board was set up, I thought, to counter IHUB
(11)
petemantx
10/12/2018 9:02:37 AM
49824
Mo: Thanks for making it clear for all who own
(4)
AlanC
10/12/2018 8:59:03 AM
49823
I have a major beef with the Cancer Society but
(4)
petemantx
10/12/2018 8:57:33 AM
49822
Yes not following blindly and creating discussion
(4)
bejamin
10/12/2018 8:57:18 AM
49821
AGREE generally to all that is in your post. That
(4)
NotRichYet2
10/12/2018 8:33:57 AM
49820
A very reasonable analysis Mo. I think if we had
(2)
Squar
10/12/2018 7:40:56 AM
49819
I have reread the Preferred Stock and Warrant
(14)
Mo
10/12/2018 12:19:51 AM
49818
It's because he's been busy here and forgot to go
Drano
10/11/2018 11:28:51 PM
< Previous
Next >
Recent Articles
How Elon Musk's Market Predictions Missed the Mark
Emerging AI Influencers: C3.ai and SoundHound AI Shine Bright
Unlocking Defense Potential: Palantir Technologies' Growth
Wells Fargo Predicts Crude Oil Prices May Rebound Soon
Thyssenkrupp Steel Division Faces Tough Decisions Ahead
The Human Touch Behind Smarter AI Models in Today's Tech
Understanding the Challenges of Gene Therapy for Sickle Cell Disease
Eli Lilly's Path to a $2 Trillion Market Valuation by 2030
Exploring Chevron's Reliable Dividend Growth Strategies
China's Economic Strategies Spark Investor Optimism
Radico Khaitan Launches Barrel Blush: A New Whisky Experience
Intel's Leap: Navigating Geopolitics and Semiconductor Challenges
China's Stimulus Measures and Global Economic Dynamics Explored
Exploring the Decline in Gen X's Discretionary Spending Patterns
Understanding the Future Growth Potential of TSMC and ASML
Elliott Investment Management's Bid for Citgo Explained
Navigating the Turmoil of Hong Kong's Commercial Real Estate Market
Market Experts Warn of Possible Stock Market Meltup Ahead
Understanding Market Dynamics: Oil's Bearish Shift Explained
Bitcoin Surges Amid Global Rate Cuts – A New Wave of Interest
Caution Ahead: European Markets Navigate Economic Challenges
Discovering the Potential of Chinese Stocks with FLCH ETF
Qualcomm's Ambitious Takeover Plans: Prospects and Challenges
Citigroup Enhances Controls to Combat Fraud and Misconduct
Three Major Economic Questions Shaping Our Future Today
Impact of Upcoming Presidential Election on Textile Retail Sector
Mark Cuban's Evolving Political Views and Support for Trump
Warren Buffett's Recent Stock Moves and Income Insights
REA Group Pursues Rightmove: A Competitive Takeover Insight
OpenAI Executives Work to Retain Ilya Sutskever Amid Departures
Exploring Unique News Stories Beyond the Ordinary
Understanding the Ripple Effects of Tariffs on Inflation
Impact of Recent Fed Rate Movements on Global Central Banks
TD Bank Faces Criminal Charges for Money Laundering Issues
Exploring the Resurgence of Nuclear Energy Investments
Xi Jinping Leads Economic Meeting to Foster Growth in China
Wells Fargo Predicts Potential Recovery in Crude Oil Prices
Europe's Economic Dilemma: Growth or Stagnation Ahead?
China's Recent Economic Strategies: What You Need to Know
UBS Predicts Nuclear Power Resurgence as Global Demand Grows
Strategies for Strengthening Your Investment Portfolio Now
Strategic Moves for Investors as Fed Eases Monetary Policies
Weekly Stock Picks: Highlights from the Market's Movers
Growth Opportunities in Tech: Palantir and Symbotic Insights
Kamala Harris Holds a Narrow Lead Over Trump in Key States
Unlocking Potential: The Influence of Digital Media on Companies
Apple Harbors Ambivalence on OpenAI While Nvidia and Microsoft Engage
Exploring the Quick Brown Fox's Legacy Beyond Words
Nokia Partners with Vodafone Idea for Enhanced 4G and 5G Connectivity
Thrive Capital's Bold Bet on OpenAI's Future Growth Potential
The Ongoing Conflict Between WordPress and WP Engine
US Stocks Show Mixed Performance Amid Jobs Data Anticipation
Meta Faces Hefty €91M Fine Over Password Security Breach
Harris Advocates for Stronger Immigration Measures and Reform
OpenAI Plans Price Increase for ChatGPT Subscription Service
Investing Wisely: Top AI-Driven Stocks to Consider Now
Hurricane Helene's Aftermath: A Battleground of Recovery Efforts
Intel's Latest Rumors: What Investors Should Know Today
Mark Spitznagel Discusses Potential Market Corrections Ahead
Exploring China's Nature Reserve Network and Its Impact
Iranian Hackers Indicted for Affecting US Election Integrity
Learnologyworld Launches New Domain and Strategic Partnerships
Intel's Buyout Rebuff: Market Reactions and Future Outlook
Unresolved Wage Negotiations: IAM and Boeing in Dispute
Federal Reserve Signals Possible Interest Rate Changes Ahead
Summit Bancshares, Inc. Declares Special Dividend Announcement
TD Bank's Legal Challenges: A Potential Guilty Plea Ahead
Boeing's Ongoing Struggles with Labor and Quality Challenges
Elon Musk's Controversial Move to Ban Journalist Raises Eyebrows
ZYUS Life Sciences Secures Unsecured Loan for Growth Initiatives
Market Trends: Insights on the S&P 500 Bull Cycle
Israel's Bold Airstrike on Hezbollah's Nasrallah Following UN Speech
Insights on Title Loan Trends from ChoiceCash's New Studies
Maximizing Savings: Smart Ways to Shop at Costco
Impact of Proposed Vehicle Regulations on US Automakers
Lululemon Investors Urged to Act in Class Action Case
Critical Update for Extreme Networks Investors on Class Action
Investors Urged to Join Class Action Against WEBTOON Entertainment
Investors Urged to Act: Key Updates on Sprinklr Lawsuit
Stellantis Investors Urged to Join Class Action for Losses
Orthofix Medical Investors Alert: Class Action Deadline Approaches
Methode Electronics Investors Urged to Act Before Deadline
Super Micro Computer Investors Urged to Take Action Soon
TELUS Expands Investment in TELUS Digital Shares Significantly
Investigation Launched into AXT, Inc. by Kahn Swick & Foti
Continued Investigation of Verrica Pharmaceuticals Inc. Leadership
Unity in Public Health: A Global Summit Inspires Action
Apple Exits OpenAI Investment Talks as Major Funding Rounds Shift
Warren Buffett's Ongoing Diversification at Bank of America
Important Notice for WEBTOON Entertainment Investors – Act Now!
Paragon 28, Inc. Faces Legal Challenges: Investors Take Note
Indivior PLC Investors Now Have a Chance to Lead Lawsuit
Nvidia's Price Surge Predicted by Expert Amid AI Growth
Evolus Expands Stock Incentives to New Non-Executive Roles
Cresco Labs Board of Directors Sees Recent Changes
Legal Action Announced for Metagenomi Investors – Key Details
Understanding Your Rights as an Allarity Therapeutics Investor
Investors Urged to Explore Legal Action Against Flux Power
Understanding the Class Action Against Metagenomi, Inc. MGX
Metagenomi, Inc. Investors File Class Action Under SEC Laws